76961-0101 Rolvedon - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

76961-0101

Brand Name:

Rolvedon

Generic Name:

Eflapegrastim-xnst

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: EFLAPEGRASTIM

Strength: 13.2

Unit: mg/.6mL

Packages:

Code: 76961-0101-01

Description: .6 mL in 1 SYRINGE, GLASS (76961-101-01)

Effective Date: Oct. 18, 2022

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Granulocyte colony stimulating factor

Orphan Drug Designation:

Status:

In Use